Open-labeled Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients (pILIT)

NCT02301884 Phase 1 COMPLETED

The investigators performed open-labeled pilot study which evaluates the efficacy and safety of allergen-specific intralymphatic immunotherapy (ILIT) for allergens including Dermatophagoides farinae (Df), Dermatophagoides pteronyssinus (Dp), cat, and dog that are sensitized and provoke rhinitis-related symptoms in patients with allergic rhinitis.

Details

Lead sponsor	Gachon University Gil Medical Center
Phase	Phase 1
Status	COMPLETED
Enrolment	12
Start date	2013-11
Completion	2015-03

Conditions

• Allergic Rhinitis

Interventions

• Allergen extract

Primary outcomes

• RQLQ — Baseline and 4 months after the first injection
  Rhinoconjunctivitis Quality of Life Questionnaire

Countries

South Korea